GENEVA, Oct. 1 -- INCYTE CORPORATION filed a patent application (US2026/019058) for “COMBINATION TREATMENTS COMPRISING ANTICANCER AGENTS AND AN AN TI-TGFPR2/PD-L BISPECIFIC ANTIBODY”. With publication no. WO/2026/193371, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....